using biostatistics to break the barriers of adopting new medicines /
First Statement of Responsibility
Robert B. Hopkins, PATH Research Institute, St. Joseph's Healthcare Hamilton, Department of Clinical Epidmiology & Biostatistics, Faculty of Health Sciences, McMaster University, Ron Goeree, MA, PATH Research Institute, St. Joseph's Healthcare Hamilton, Department of Clinical Epidmiology & Biostatistics, Faculty of Health Sciences, McMaster University .
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
xxii, 254 pages :
Other Physical Details
illustrations ;
Dimensions
26 cm.
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
Includes bibliographical references and index.
CONTENTS NOTE
Text of Note
Regulation, reimbursement, and health technology assessment -- Requirements and sources of data to complete an HTA -- Meta-analysis -- Network meta-analysis -- Bayesian methods -- Survival analysis -- Costs and cost of illness studies -- Health-related quality of life -- Missing data methods.
0
TOPICAL NAME USED AS SUBJECT
Medical technology-- Cost effectiveness.
Medical technology-- Evaluation-- Statistical methods.